Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006.

Year-to-date, the iShares Biotechnology ETF return is roughly 4.88% so far, and was up about 3.47% over the last 12 months (as of 02/03/2025). IBB has traded between $124.64 and $149.47 in this past ...

Grayscale, a major player in the cryptocurrency investment space, has debuted its Bitcoin Miners ETF on the New York Stock ...

United States Natural Gas Fund, LP has recently disclosed its Monthly Account Statement for the period ended December 31, 2024. The statement reveals a robust financial performance with notable gains ...